李斌 刘曼 宋晓文 庄伟 董晓梦 陈金波
【摘要】 重症肌无力(myasthenia gravis,MG)是一种自身抗体介导累及神经肌肉接头(NMJ)突触后膜的自身免疫性疾病,具有骨骼肌易疲劳性、症状波动性等特点,抗肌肉特异性受体酪氨酸激酶(MuSK)抗体阳性重症肌无力(MMG)患者占MG的5%~10%。与抗乙酰胆碱受体(AChR)抗体阳性的MG相比,具有发病时间早、病情重、疗效不佳、病情易进展等特点,其中急性发作和延髓肌受累是最常见、最重要的临床特点。目前,国内外对关于MuSK抗体相关发病机制研究缺乏,其发参与的信号通路亦不明确。本文就MuSK抗体介导的MG发生发展过程进行综述,以期对未来该病的诊治及预防提供理论依据。
【关键词】 重症肌无力 肌肉特异性受体酪氨酸激酶抗体 抗乙酰胆碱受体 发病机制 神经-肌肉接头
Research Progress of Myasthenia Gravis with Antibodies to MuSK/LI Bin, LIU Man, SONG Xiaowen, ZHUANG Wei, DONG Xiaomeng, CHEN Jinbo. //Medical Innovation of China, 2021, 18(15): -180
[Abstract] Myasthenia gravis (MG) is an autoimmune disease with autoantibody mediated involvement of the postsynaptic membrane of the neuromuscular junction (NMJ), which is characterized by skeletal muscle fatigue and symptom fluctuation, etc. The patients with myasthenia gravis (MMG) positive anti-muscle-specific receptor tyrosine kinase (MuSK) antibody account for 5%-10% of MG. Compared with the anti-acetylcholine receptor (AChR) antibody positive MG, it has the characteristics of early onset, severe disease, poor efficacy and easy progression, among which acute attack and medulla oblongata muscle involvement are the most common and important clinical characteristics. At present, there is a lack of research on the pathogenesis related to MuSK antibody at home and abroad, and the signaling pathway involved in MuSK antibody is not clear. In this paper, the occurrence and development of MuSK-mediated MG were reviewed in order to provide theoretical basis for the diagnosis, treatment and prevention of the disease in the future.
[Key words] Myasthenia gravis Muscle-specific tyrosine kinase Against acetylcholine receptor Pathogenesis Neuromuscular junctio
First-author’s address: Binzhou Medical University Hospital, Binzhou 256600, China
doi:10.3969/j.issn.1674-4985.2021.15.043
重癥肌无力(myasthenia gravis,MG)是一种影响神经-肌肉接头(neuromuscular junctio,NMJ)的自身免疫性疾病,以骨骼肌无力、晨轻暮重、症状波动为主要临床特征,约85%的MG由乙酰胆碱受体(acetylcholine receptor,AChR)抗体介导自身免疫发生的过程[1]。近年来发现抗肌肉特异性酪氨酸激酶抗体(muscle specific kinase antibody,MuSK-Ab)参与MG发生发展过程,其中MuSK-Ab
阳性的重症肌无力(MuSK-myasthenia gravis,MMG)患者占全部MG的5%~8%[2],其为神经肌肉源性蛋白受体的组成部分,参与AChR聚集和维持NMJ功能完整,在信号传导过程起着重要作用,其抗体滴度与病情严重程度密切相关[1-2]。MMG通常以眼肌、延髓肌麻痹为主要临床特征,无明显胸腺改变,肌无力症状波动不典型、乙酰胆碱酯酶抑制剂疗效不佳和电生理测试阴性等临床表现,该病急性发作及短时间内迅速恶化发生肌无力危象,严重时发生可全身肌肉无力直至肌肉萎缩[2]。……